ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,167.66
0.25%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Medicenna Therapeutics Corporation (QB) (MDNAF) Share Price

MDNAF Medicenna Therapeutics Corporation (QB)

1.55
-0.15 (-8.82%)
14 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Medicenna Therapeutics Corporation (QB) USOTC:MDNAF OTCMarkets Common Stock  Ordinary Shares Canada
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.15 -8.82 1.55 1.51 1.62 1.67 1.52 1.67 117,400 20:00:10   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -10.05M -0.1443 -14.69 147.63M
 Type  Size  Price  Time  Units 
 23 100 1.5499 19:58:11 USD
 
Recent News
DateTimeSource
HeadlineMore MDNAF News
14/05/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
10/05/202421:05EDGAR2Form POS AM - Post-Effective amendments for registration statement
06/03/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
22/02/202401:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
13/02/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
21/11/202315:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Period
Draw mode
Data Downloads for MDNAF

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Medicenna Therapeutics Corporation (QB) Articles